MEDFORD, NY -- (MARKET WIRE) -- March 14, 2007 -- Chembio Diagnostics, Inc. (OTCBB: CEMI) has been issued United States Patent Number 7,189,522 for its "Dual Path Immunoassay Device" and is now beginning to actively seek collaborations for this exciting new technology platform. Additional patent protection is also pending both in the U.S. and worldwide.
